Literature DB >> 8532841

Radiation-induced autophosphorylation of epidermal growth factor receptor in human malignant mammary and squamous epithelial cells.

R K Schmidt-Ullrich1, K Valerie, P B Fogleman, J Walters.   

Abstract

In an effort to identify events initiating up-regulation of epidermal growth factor receptor after single and repeated radiation exposures, we investigated the role of epidermal growth factor receptor, a receptor protein tyrosine kinase, in radiation-induced signal transduction. Human malignant mammary, MCF-7, and squamous, A431, cells showed low baseline phospho-tyrosine levels of epidermal growth factor receptor, permitting reproducible dose-dependent stimulation of epidermal growth factor receptor autophosphorylation after exposure to epidermal growth factor. MCF-7 cells exhibited a mean 2.3-fold increase (95% confidence interval: 1.91, 2.65; P < 0.0001) in levels of epidermal growth factor phosphorylation in response to exposures of 2 Gy, which was substantially less than the epidermal growth factor receptor Y phosphorylation induced by epidermal growth factor. A quantitatively similar radiation response was seen in A431 cells. In the dose range of 1 to 4 Gy, no clear dose response was seen. There was a rapid induction of radiation-induced epidermal growth factor receptor Y phosphorylation, starting within 2 min, with maximum values between 0.5 and 5 min after radiation exposure followed by a slower decline to baseline levels after 20 min. The data presented identify the epidermal growth factor receptor protein tyrosine kinase associated with the plasma membrane as one target for ionizing radiation in the dose range used in radiotherapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8532841

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  25 in total

1.  FTS is responsible for radiation-induced nuclear phosphorylation of EGFR and repair of DNA damage in cervical cancer cells.

Authors:  Sridhar Muthusami; D S Prabakaran; Jae-Ran Yu; Woo-Yoon Park
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-24       Impact factor: 4.553

2.  Differential activation of mitogen-activated protein kinases following high and low LET radiation in murine macrophage cell line.

Authors:  Himanshi Narang; Nagesh Bhat; S K Gupta; S Santra; R K Choudhary; S Kailash; Malini Krishna
Journal:  Mol Cell Biochem       Date:  2008-12-27       Impact factor: 3.396

3.  Augmentation of radiation response by panitumumab in models of upper aerodigestive tract cancer.

Authors:  Tim J Kruser; Eric A Armstrong; Amol J Ghia; Shyhmin Huang; Deric L Wheeler; Robert Radinsky; Daniel J Freeman; Paul M Harari
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-10-01       Impact factor: 7.038

Review 4.  Epidermal growth factor receptor and bladder cancer.

Authors:  A J Colquhoun; J K Mellon
Journal:  Postgrad Med J       Date:  2002-10       Impact factor: 2.401

Review 5.  Combining targeted agents and hypo- and hyper-fractionated radiotherapy in NSCLC.

Authors:  Fiona McDonald; Sanjay Popat
Journal:  J Thorac Dis       Date:  2014-04       Impact factor: 2.895

6.  Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience.

Authors:  Paolo Borghetti; Marco Lorenzo Bonù; Elisa Roca; Sara Pedretti; Emiliano Salah; Anna Baiguini; Diana Greco; Luca Triggiani; Marta Maddalo; Niccolò Giaj Levra; Filippo Alongi; Stefano Maria Magrini; Michela Buglione
Journal:  In Vivo       Date:  2018 Jan-Feb       Impact factor: 2.155

Review 7.  Management of non-small cell lung cancer with EGFR mutation: the role of radiotherapy in the era of tyrosine kinase inhibitor therapy-opportunities and challenges.

Authors:  Bing Xia; Shirong Zhang; Shenglin Ma
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

8.  AC480, formerly BMS-599626, a pan Her inhibitor, enhances radiosensitivity and radioresponse of head and neck squamous cell carcinoma cells in vitro and in vivo.

Authors:  Mylin A Torres; Uma Raju; David Molkentine; Oliver Riesterer; Luka Milas; K Kian Ang
Journal:  Invest New Drugs       Date:  2010-02-02       Impact factor: 3.850

Review 9.  Targeting nonhomologous end-joining through epidermal growth factor receptor inhibition: rationale and strategies for radiosensitization.

Authors:  Bipasha Mukherjee; Hak Choy; Chaitanya Nirodi; Sandeep Burma
Journal:  Semin Radiat Oncol       Date:  2010-10       Impact factor: 5.934

10.  ErbB2, FoxM1 and 14-3-3ζ prime breast cancer cells for invasion in response to ionizing radiation.

Authors:  D M Kambach; V L Sodi; P I Lelkes; J Azizkhan-Clifford; M J Reginato
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.